Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (2)

2024

  1. Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study

    Pharmaceuticals, Vol. 17, Núm. 10

2020

  1. Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

    The Lancet, Vol. 395, Núm. 10238, pp. 1705-1714